Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans

Biochem Biophys Res Commun. 2002 Mar 8;291(4):1006-13. doi: 10.1006/bbrc.2002.6548.

Abstract

The antifungal activity and mechanism of HP (2-20), a peptide derived from the N-terminus sequence of Helicobacter pylori Ribosomal Protein L1 were investigated. HP (2--20) displayed a strong antifungal activity against various fungi, and the antifungal activity was inhibited by Ca(2+) and Mg(2+) ions. In order to investigate the antifungal mechanism(s) of HP (2-20), fluorescence activated flow cytometry was performed. As determined by propidium iodide staining, Candida albicans treated with HP (2-20) showed a higher fluorescence intensity than untreated cells and was similar to melittin-treated cells. The effect on fungal cell membranes was examined by investigating the change in membrane dynamics of C. albicans using 1,6-diphenyl-1,3,5-hexatriene as a membrane probe and by testing the membrane disrupting activity using liposome (PC/PS; 3:1, w/w) and by treating protoplasts of C. albicans with the peptide. The action of peptide against fungal cell membrane was further examined by the potassium-release test, and HP (2-20) was able to increase the amount of K(+) released from the cells. The result suggests that HP (2-20) may exert its antifungal activity by disrupting the structure of cell membrane via pore formation or directly interacts with the lipid bilayers in a salt-dependent manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / antagonists & inhibitors
  • Antifungal Agents / pharmacology*
  • Bacterial Proteins / antagonists & inhibitors
  • Bacterial Proteins / pharmacology*
  • Calcium / pharmacology
  • Candida albicans / cytology
  • Candida albicans / drug effects*
  • Candida albicans / physiology
  • Cell Membrane / drug effects
  • Cell Wall / physiology
  • Dose-Response Relationship, Drug
  • Flow Cytometry
  • Helicobacter pylori
  • Kinetics
  • Liposomes / analysis
  • Magnesium / pharmacology
  • Microbial Sensitivity Tests
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / pharmacology*
  • Potassium / metabolism
  • Protoplasts / drug effects
  • Protoplasts / physiology
  • Regeneration
  • Ribosomal Proteins / chemistry

Substances

  • Antifungal Agents
  • Bacterial Proteins
  • Hp (2-20) protein, Helicobacter pylori
  • Liposomes
  • Peptide Fragments
  • Ribosomal Proteins
  • ribosomal protein L1
  • Magnesium
  • Potassium
  • Calcium